Progesterone replacement with vaginal gel versus i.m. injection: Cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts

Human Reproduction

Volumn 29, Issue 8, 2014, Pages 1706-1711

  Shapiro, Daniel B ^a   Pappadakis, Jennifer A ^b   Ellsworth, Nancy M ^a   Hait, Howard I ^c   Nagy, Zsolt Peter ^a  

^a REPRODUCTIVE BIOLOGY ASSOCIATES   (United States)

^b Actavis Inc   (United States)

^c Edenridge Associates   (United States)

Author keywords

Frozen embryo transfer; I.m. progesterone; Luteal phase support; Progesterone gel; Vaginal progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; AGENTS USED INTRAVAGINALLY;

ARTICLE; BLASTOCYST; CLINICAL PROTOCOL; DRUG DOSAGE FORM COMPARISON; EMBRYO TRANSFER; FERTILIZATION IN VITRO; GEL; HORMONE SUBSTITUTION; INFERTILITY; INFERTILITY THERAPY; INJECTION; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; OOCYTE MATURATION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; VITRIFICATION; COMPARATIVE STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; RETROSPECTIVE STUDY;

FEMALE; FERTILIZATION IN VITRO; HUMANS; INJECTIONS, INTRAMUSCULAR; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; RETROSPECTIVE STUDIES; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84904334009     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu121     Document Type: Article

References (30)

1. AbdelHafez FF, Desai N, Abou-Setta AM, Falcone T, Goldfarb J. Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-analysis. Reprod Biomed Online 2010; 20:209-222.
2. Berger BM, Phillips JA. A retrospective analysis of pregnancy outcomes in recipients of frozen/thawed embryos (FET) from donated oocytes at a large assisted reproductive technology (ART) center. Fertil Steril 2008; 90:S459.
3. Berger BM, Phillips JA. Pregnancy outcomes in oocyte donation recipients: vaginal gel versus intramuscular injection progesterone replacement. J Assist Reprod Genet 2012;29:237-242.
4. Cercas R, Villas C, Pons I, Braña C, Fernandez-Shaw S. Vitrification can modify embryo cleavage stage after warming. Should we change endometrial preparation? J Assist Reprod Genet 2012;29:1363-1368.
5. Chang CC, Shapiro DB, Bernal DP, Wright G, Kort HI, Nagy ZP. Two successful pregnancies obtained following oocyte vitrification and embryo re-vitrification. Reprod Biomed Online 2008;16:346-349.
6. Dal Prato L, Bianchi L, Cattoli M, Tarozzi N, Flamigni C, Borini A. Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial. Reprod BioMed Online 2008;16:361-367.
7. Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Fertil Steril 2006;86:92-97.
8. FatemiHM.The luteal phase after 3 decades of IVF: whatdowe know? Reprod Biomed Online 2009;19 (Suppl. 4):4331-4344.
9. Feinberg EC, Beltsos AN, Nicolaou E, Marut EL, Uhler ML. Endometrin as luteal phase support in assisted reproduction. Fertil Steril 2013;99:174-178.
10. Gibbons WE, Toner JP, Hamacher P, Kolm P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril 1998; 69:96-101.
11. Jobanputra K, Toner JP, Denoncourt R, Gibbons WE. Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles. Fertil Steril 1999;72:980-984.
12. Kahraman S, Karagozoglu SH, Karlikaya G. The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial. Fertil Steril 2010;94:761-763.
13. Kaser DJ, Ginsburg ES, Missmer SA, Correia KF, Racowsky C. Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for Day 3 cryopreserved embryo transfer. Fertil Steril 2012;98:1464-1469.
14. Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril 2008;90:186-193.
15. Maheshwari A, Griffiths S, Bhattacharya S. Global variations in the uptake of single embryo transfer. Hum Reprod Update 2011;17:107-120.
16. Mitwally MF, Diamond MP, Abuzeid M. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 2010; 93:554-569.
17. Nawroth F, Ludwig M. What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols? Hum Reprod 2005; 20:1127-1134.
18. Practice Committee of the American Society for Reproductive Medicine. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin. Fertil Steril 2008;89:789-792.
19. Racowsky C, Vernon M, Mayer J, Ball GD, Behr B, PomeroyKO,Wininger D, Gibbons W, Conaghan J, Stern JE. Standardization of grading embryo morphology. Fertil Steril 2010;94:1152-1153.
20. Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, Checa MA. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril 2013; 99:156-162.
21. SART (Society for Assisted Reproductive Technology) Clinic Outcome Reporting System. https://www.sartcorsonline.com/rptCSR-PublicMultYear.aspx? ClinicPKID=0 (24 February 2014, date last accessed).
22. Schoolcraft WB, Hesla JS, Gee MJ. Experience with progesterone gel for luteal support in a highly successful IVF programme. Hum Reprod 2000; 15:1284-1288.
23. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of Day 5 or Day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril 2008;89:20-26.
24. Silverberg KM, Vaughn TC, Hansard LJ, Burger NZ, Minter T. Vaginal (Crinone 8%) gel versus intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial. Fertil Steril 2012;97:344-348.
25. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983;305:707-709.
26. van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2011:CD009154.
27. Van Steirteghem AC, Nagy ZP, Joris H, Liu J, Staessen C, Smitz J,Wisanto A, Devroey P. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod 1993;8:1061-1066.
28. Williams SC, Donahue J, Muasher SJ. Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: An analysis of serum progesterone levels and pregnancy rates. Fertil Steril 2000;74:S209.
29. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study. Fertil Steril 2010;94: 2596-2599.
30. Zarutskie PW, Phillips JA. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone. Fertil Steril 2009;92:163-169.